Arvinas, Inc.
Records under this name other than patents Arvinas, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,239,711 | Cereblon ligands and bifunctional compounds comprising the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,071,164 | Estrogen-Related Receptor Alpha Based Protac Compounds and Associated Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 11,352,351 | Compounds and Methods for the Targeted Degradation of Androgen Receptor Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,427,548 | Compounds and methods for the targeted degradation of androgen receptor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,312,316 | Compounds and Methods for the Targeted Degradation of Androgen Receptor Formerly held In force · High confidence | In force | High confidence | |
| US 10,730,870 | Compounds and Methods for the Enhanced Degradation of Targeted Proteins Formerly held In force · High confidence | In force | High confidence | |
| US 11,512,083 | Compounds and Methods for the Enhanced Degradation of Targeted Proteins Formerly held In force · High confidence | In force | High confidence | |
| US 12,264,157 | Compounds and Methods for the Enhanced Degradation of Targeted Proteins Formerly held In force · High confidence | In force | High confidence | |
| US 10,946,017 | Tank-binding kinase-1 PROTACs and associated methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,772,962 | Compounds and Methods for the Targeted Degradation of Bromodomain-Containing Proteins Formerly held In force · High confidence | In force | High confidence |